3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Polycystic Ovary Syndrome
3
Peripheral Nervous System Diseases
3
Ovarian Neoplasms
3
Lung Neoplasms
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Stomach Neoplasms
2
Pseudomyxoma Peritonei
2
Ototoxicity
2
Neurofibromatosis 1
2
Neoplasms
2
Liver Neoplasms
2
Hearing Loss
2
Head and Neck Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Weight Loss
1
Ulcer
1
Tongue Neoplasms
1
Tomaculous neuropathy
1
Thrombocythemia, Essential
1
Squamous Cell Carcinoma of Head and Neck
1
Small Cell Lung Carcinoma
1
Salivary Gland Neoplasms
1
Renal Insufficiency, Chronic
1
Renal Artery Obstruction
1
Radiation-Induced Mucositis
1
Radiation Pneumonitis
1
Pulmonary Embolism
1
Primary Myelofibrosis
1
Primary Graft Dysfunction
1
Interventions
Oxaliplatin
290
Capecitabine
206
Fluorouracil
181
Cisplatin
168
Docetaxel
138
S 1 (combination)
132
Paclitaxel
121
Leucovorin
116
Irinotecan
106
pembrolizumab
103
Trastuzumab
71
apatinib
56
Nivolumab
56
sintilimab
45
Drug Therapy
43
Surgical Procedures, Operative
37
Radiotherapy
37
Bevacizumab
37
Ramucirumab
34
titanium silicide
31
Hyperthermic Intraperitoneal Chemotherapy
30
Epirubicin
30
Carboplatin
30
tislelizumab
28
Cyclophosphamide
27
XELOX
24
Tegafur
23
Folfox protocol
22
Albumin-Bound Paclitaxel
22
camrelizumab
21
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Interventional
×
Stomach Neoplasms
×
Acetylcysteine
×
Clear all
NCT07245095
2025-11-24
NACSIMET
Hospital General de Mexicali
Phase 2
Recruiting
132 enrolled
NCT01653171
2018-04-10
PRUE
Pontificia Universidad Catolica de Chile
Phase 4
Completed
230 enrolled